InnoGene Co (344860.KQ) Stock Price

InnoGene Co Price

CLOSED
1,323.00
​
Market closed

Over the last 6 years InnoGene Co grew revenue by 2.3% annually, reaching 8.94 B KRW. Earnings per share have grown at 2.3% per year over the last 6 years. For InnoGene Co, the net margin of 10.6% is broadly stable versus 11.0% a few years ago. At today's price the dividend yield works out to roughly 6.05%. The payout ratio is around 101% of earnings.

InnoGene Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

InnoGene Co business model & stock analysis

InnoGene Co Ltd is a company based in Seoul, South Korea, operating within the Consumer Staples sector and the Consumer products industry. The company has 77 employees and went public on April 27, 2020. Its website is http://www.innogene.com/. InnoGene focuses on research and development related to skin regeneration and anti-aging solutions, utilizing stem cell technology and fusion technology. The company develops and manufactures cosmetics aimed at skin regeneration and aging control. Additionally, InnoGene is involved in the manufacturing and distribution of medical devices. The company's primary activities revolve around creating products that address skin health and aging concerns, leveraging scientific research in stem cell applications. As a publicly traded entity, InnoGene operates under the ticker symbol 344860.KQ and is registered with the ISIN KR7344860002. The company's headquarters are located in Seoul, and it serves a market that values innovative skincare and medical device solutions. InnoGene's product portfolio includes both cosmetic and medical device offerings, targeting consumers interested in advanced skincare technologies. The company's operations are centered on research-driven development to enhance skin health and combat aging effects.

Frequently asked questions about InnoGene Co

Converted at the current exchange rate, the InnoGene Co share trades at 0.88 EUR (1,323.00 KRW).

The revenue cannot currently be calculated for InnoGene Co.

The profit cannot currently be calculated for InnoGene Co.

The P/E ratio cannot be calculated for InnoGene Co at the moment.

The P/S cannot be calculated for InnoGene Co currently.

The Eulerpool Quality Score for InnoGene Co is 2/10.

The ISIN of InnoGene Co is KR7344860002. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of InnoGene Co is 344860.KQ. The ticker symbol is used to trade InnoGene Co shares on the stock exchange.

Fair ValueTerminal
1,349.46 KRW
Over-/UndervaluationTerminal
Fairly valued
Industry
Personal Care Products
Number of shares
Employees
Revenue per Employee
116.16 M KRW
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website innogene.com
Country
South Korea
Currency
KRW
Initial public offering
Apr 27, 2020
ISIN
KR7344860002
Cusip
Y4R87G106
Market capitalization
15.82 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
23.21
P/B Ratio
0.95
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
5.66 %
Dividend
Dividend yield
6.05 %
Payout Ratio
101.22 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
22.00 %
Last updated Nov 11, 2026, 9:06 PM

InnoGene Co Peer Group

InnoGene Co FIGI

344860:KS · BBG00TCNH4X9344860:KQ · BBG00TCNH4Z7